/

Sociétés

Or

Non vérifié

Orca Bio

Ce que nous écrivons

BiotechnologieIndustrieIndustrie pharmaceutiqueOncologieSanté

20 communiqués de presse

Voir tous les communiqués de presse

28/04/2026

Industrie

Oncologie

Hygiène alimentaire

Santé

Médecine - Divers

Industrie pharmaceutique

Biotechnologie

Orca Bio Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Orca-Q® for the Treatment of High-Risk Hematologic Malignancies

Source

Émetteur

1.00

0

01/04/2026

Industrie

Biotechnologie

Industrie pharmaceutique

Santé

Oncologie

Orca Bio Announces FDA Review Extension of BLA for Orca-T for the Treatment of Hematologic Malignancies

Source

Émetteur

1.00

0

02/03/2026

Événements

Industrie

Oncologie

Santé

Biotechnologie

Santé Publique

Médecine - Divers

Industrie pharmaceutique

Orca Bio to Present Clinical Data on Its Pipeline of High-Precision Cell Therapies at the 52nd Annual Meeting of the EBMT

Source

Émetteur

1.00

0

05/02/2026

Biotechnologie

Industrie pharmaceutique

Santé

Oncologie

Industrie

Orca Bio Presents New Data at the 2026 Tandem Meetings of ASTCT® and CIBMTR® Reinforcing Orca-T® as a Durable, High-Precision Cell Therapy for Hematological Malignancies

Source

Émetteur

1.00

0

21/01/2026

Science

Biologie

Biotechnologie

Industrie pharmaceutique

Oncologie

Santé

Médecine - Divers

Événements

Industrie

Orca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 2026 Tandem Meetings of ASTCT® and CIBMTR®

Source

Émetteur

1.00

0

09/01/2026

Oncologie

Santé

Biologie

Santé Publique

Industrie pharmaceutique

Biotechnologie

Orca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization

Source

Émetteur

1.00

0

05/01/2026

Événements

Web et Réseaux Sociaux

Santé

Biologie

Industrie pharmaceutique

Oncologie

Orca Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference

Source

Émetteur

1.00

0

15/12/2025

Industrie

Oncologie

Santé

Biologie

Médecine - Divers

Industrie pharmaceutique

Biotechnologie

Orca Bio Announces Orca-T® Phase 3 Data Published in Blood Demonstrate Significant Improvement in Survival Free from Chronic Graft versus Host Disease in Patients with Hematological Malignancies

Source

Émetteur

1.00

0

08/12/2025

Industrie

Biotechnologie

Santé

Industrie pharmaceutique

Médecine - Divers

Oncologie

Orca Bio Presents New Clinical Data on its Pipeline of High-Precision Cell Therapies including Orca-Q® Without GvHD Prophylaxis and Orca-T/CAR-T Combination Therapy at the 67th ASH Annual Meeting

Source

Émetteur

1.00

0

06/12/2025

Événements

Expos

Industrie

Science

Biotechnologie

Médecine - Divers

Biologie

Santé Publique

Industrie pharmaceutique

Santé

Oncologie

Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting

Source

Émetteur

1.00

0

Followers

0

Compatibilité

0